Column: In the pipeline
29 September 2011 In the Pipeline
You have to make space for good sense when thinking about safety, argues Derek Lowe

© David Graham Illustration
But I don’t have to exaggerate the toxicity or reactivity of any of the compounds in that f ile. The truth about them is suf icient. We organic chemists really do work with some terrible chemicals, and it’s up to us to keep them from causing havoc. People really do get injured, poisoned, or sometimes even killed using such things, so it’s worth asking how chemists work while knowing about these cases – and asking, as well, if there are reagents that are just not worth the risk at all.
I think most chemists, when they read most accident reports, think to themselves ‘Well, of course – I wouldn’t have done it that way’. Sometimes that response is completely justif ied. There are accidents that just elicit groans, such as an incident with a summer undergraduate student working with an old colleague of mine. This worthy experimentalist managed to carve off the required amount of sodium with a small knife, while firmly gripping the block of metal with his other bare hand. It’s not hard to feel some reassurance at such cases, which is one of the lesser-known reasons that these stories get told so often. But there are other, more disturbing tales that don’t provide any room to feel superior. Karen Wetterhahn’s death at Dartmouth from a seemingly trivial spill of dimethylmercury – onto a gloved hand – is one of the most famous examples.
The main thing one takes from a story like that is a f ierce determination never to work with dimethylmercury. That’s not a bad lesson by itself, but it leaves open the possibility that there are other such hazards waiting unknown. The chances of these are low, but not zero, as the famous example of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) shows. That compound, which is a perfectly plausible small intermediate for a medicinal chemist to make, causes irreversible Parkinson’s disease on exposure, and (alarmingly) this was not an effect that anyone could have predicted by looking at its structure. It’s the result of a terrible cascade: the compound is metabolised readily to a reactive intermediate that happens to be an excellent substrate for a transporter protein – and then also happens to be an excellent inhibitor of a key metabolic enzyme. One could not have designed a better small molecule to kill off dopamine rich neurons. The thought of how many other such compounds might be waiting out there does not make for a restful evening.
These examples serve to show that there are compounds that many – if not most – chemists just will not work with. I would not use either dimethylmercury or MPTP. No single reaction I have is important enough for me to take the risk. There are other things I can make, and other ways that I can make them, and it’s not very likely, fortunately, that any drug intermediate is going to be made using dimethylmercury. (I imagine that the scale-up group would come for me with knives drawn. Even if I survived my own chemistry, I’d have them to deal with.) Others have used it in the past without being harmed, of course, but I have no desire to see if my lab technique is sound enough to add my name to their list, for fear of ending up on another list entirely.
The only thing to do is: exercise due caution. I know from my own experience that most of the compounds I make don’t seem to do very much to enzymes and cells. The odds of my inadvertently producing an eff icient poison are low, but that doesn’t mean that I shouldn’t work in the fume hood and keep my hands clean. That said, if I were to treat every new compound I make as if it were MPTP, I wouldn’t get very much work done, would I? There’s a middle ground, and it’s up to every bench chemist to f ind a place in it. Knowing as many of the already-discovered hazards as possible is a good place to start, and probably gives the greatest return in safety for the effort.
29 September 2011 In the Pipeline
You have to make space for good sense when thinking about safety, argues Derek Lowe
30 April 2013 In the Pipeline
A can-do attitude and some lateral thinking can save time and money when it comes to exotic apparatus, says Derek Lowe
17 May 2013 Research
Barium carbonate crystals have been coaxed to form nano-flowers by controlling their chemical environment
15 May 2013 Research
The environmental legacy of salvaging gold from electronic waste can be dramatically cut using corn starch instead of cyanide
13 May 2013 Research
Engineered protein can be used to produce antivenoms and might provide long-lasting protection against bites
17 May 2013 Research
Seamless integration of electronics and tissue could be used with other artificial implants and synthetic organs